JPS61228876A - Subcataneous stay catheter - Google Patents

Subcataneous stay catheter

Info

Publication number
JPS61228876A
JPS61228876A JP60068669A JP6866985A JPS61228876A JP S61228876 A JPS61228876 A JP S61228876A JP 60068669 A JP60068669 A JP 60068669A JP 6866985 A JP6866985 A JP 6866985A JP S61228876 A JPS61228876 A JP S61228876A
Authority
JP
Japan
Prior art keywords
catheter
present
fibers
cvd
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP60068669A
Other languages
Japanese (ja)
Other versions
JPH0516872B2 (en
Inventor
北岡 健樹
越川 昭三
高部 礼法
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kureha Corp
Original Assignee
Kureha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Corp filed Critical Kureha Corp
Priority to JP60068669A priority Critical patent/JPS61228876A/en
Publication of JPS61228876A publication Critical patent/JPS61228876A/en
Publication of JPH0516872B2 publication Critical patent/JPH0516872B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Media Introduction/Drainage Providing Device (AREA)
  • Materials For Medical Uses (AREA)

Abstract

(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。
(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.

Description

【発明の詳細な説明】 本発明は持続的可動性腹膜透析等に適用する経皮留置カ
テーテルに関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a percutaneous indwelling catheter applicable to continuous mobile peritoneal dialysis and the like.

1976年、米国ボボブイッチらにより最初の臨床応用
がなされた持続的可動性膜I!透析療法(以下、CAP
Dと称する)は、血液透析(1(D )や間欠的腹膜透
析(IPD)に代わる腎不全の治療法として、欧米にお
いては急速な普及をみせ、我が国においても徐々に増加
の傾向にある。
In 1976, the first clinical application was made by Bobowich et al. in the United States of America. Dialysis therapy (hereinafter referred to as CAP)
D) has rapidly become popular in Europe and the United States as a treatment for renal failure as an alternative to hemodialysis (D) and intermittent peritoneal dialysis (IPD), and is gradually increasing in Japan as well.

CARDは血液透析(HD)或いは間欠的腹膜透析(I
PD)に比較し、社会復帰が容易で臨床症状もより改善
される等の利点を有する。しかしながら、CARDは一
方では合併症も種々報告されており、このうち最も頻度
が高く重要なものは腹膜炎である。
CARD uses hemodialysis (HD) or intermittent peritoneal dialysis (I).
Compared to PD), it has advantages such as easier reintegration into society and better clinical symptoms. However, various complications have been reported with CARD, of which the most frequent and important one is peritonitis.

近年、透析(潅流)液交換の際の汚染にt!1迩するa
S炎は軟質プラスチックスバッグによる完全開鎖システ
ムの開発やチタンアダプターの工夫等により、その誘発
率が著減している。
In recent years, contamination during dialysis (perfusion) fluid exchange has become a problem! 1 flight a
The incidence of S-flame has been significantly reduced due to the development of a completely open chain system using soft plastic bags and the development of titanium adapters.

しかしながら、カテーテルに関連する腹膜炎の発生に対
してはその対策が十分でないのが現状である。
However, the current situation is that there are insufficient measures against the occurrence of catheter-related peritonitis.

即ち、CAPDカテーテルとしてテンコツ(T enc
khoH)型、ライフカス(L ife 0ath)型
、TWH型或いはそれらの改良品等が市販されているが
、それらのCAPDカテーテルは生体皮膚組織との適合
性が悪く、カテーテルと1!膜皮膚貫通部における接合
不良、固定の不十分から感染症を生じやすく、11al
l!炎を誘発する確率が高いものである。最近、生体皮
膚組織適合性を改善するCARDカテーテルとして、皮
膚との接合部に多孔性のポリ四フッ化エチレンよりなる
カフ、7ランジ、カラーを装着したカテーテルが提案さ
れている。
That is, Tenkotsu (Tenc) is used as a CAPD catheter.
KhoH type, Life 0ath type, TWH type, and improved versions thereof are commercially available, but these CAPD catheters have poor compatibility with living skin tissue, and the catheter and 1! Infections are likely to occur due to poor bonding and insufficient fixation at the membrane-skin penetration site, and 11al
l! It has a high probability of inducing a flame. Recently, a catheter equipped with a cuff, seven lunges, and a collar made of porous polytetrafluoroethylene at the junction with the skin has been proposed as a CARD catheter that improves tissue compatibility with the skin.

しかしながら、前記カテーテルは生体皮膚組織との接触
面が比較的滑らかで、また開孔率が小さい為、生体皮膚
組織の侵入生着性に劣り、更に7ランジが比較的大きな
つば状であるため生体挿入時の切間面積が大きくなる等
の欠点を有している。
However, since the contact surface with living body skin tissue is relatively smooth and the porosity of the catheter is small, the penetration and engraftment of living body skin tissue is poor, and furthermore, the 7-lunge has a relatively large brim shape, so it It has drawbacks such as a large incision area during insertion.

また、前記カテーテルにおいて、単に開孔率を大きくし
た成形体を用いたのでは、材料強度が低下し、経皮的イ
ンブラントに要求される外力に対する耐久性が損われる
Furthermore, if a molded body with a simply increased porosity is used in the catheter, the material strength will decrease and the durability against external forces required for percutaneous implants will be impaired.

従って、実用段階で固定の不十分による感染。Therefore, infection due to insufficient fixation occurs during the practical stage.

炎症等の不都合を生じることなく、しかも耐久性グに優
れるCARDカテーテルは未だないのが現状である。
At present, there is currently no CARD catheter that does not cause inconveniences such as inflammation and has excellent durability.

本発明者等は前記実情に鑑み、生体皮膚組織適合性に優
れるCARDカテーテルの提供を目的とし鋭il研究の
結果、本発叫の完成に至った。即ち、本発明は生体適合
性プラスチックスよりなるカテーテルの皮膚貫通部位テ
ルに、耐熱性繊維集合体層を形成してなる経皮留置カテ
ーテルに係る。特開昭58−48293は生体適合性繊
維層と、プラスチック層よりなる医療用生体適合性プラ
スチックス複合材を開示するが、具体的な用途に関して
は何等開示していない。
In view of the above-mentioned circumstances, the present inventors conducted extensive research with the aim of providing a CARD catheter with excellent compatibility with living skin and tissue, and as a result, they completed the present proposal. That is, the present invention relates to a percutaneous indwelling catheter in which a heat-resistant fiber aggregate layer is formed at the skin-penetrating site of a catheter made of biocompatible plastics. JP-A-58-48293 discloses a biocompatible plastics composite material for medical use consisting of a biocompatible fiber layer and a plastic layer, but does not disclose any specific uses thereof.

本発明の特徴の1つは、前記特開昭58−48293に
開示する炭素材料或いはセラミックス材料等の硬質材料
を、゛それらの繊維集合体として用いた複合材Φ1て“
CARD等の経皮留置カテーテルにへ応用することを可
能にしたことにある。
One of the features of the present invention is that a hard material such as a carbon material or a ceramic material disclosed in the above-mentioned Japanese Patent Application Laid-Open No. 58-48293 is used as a composite material Φ1 using the fiber aggregate thereof.
The reason is that it has become possible to apply it to percutaneous indwelling catheters such as CARD.

また、第2の特徴は皮膚貫通部位の複合材は、空隙(見
掛けの比表面積)が大きく、又は“開放気孔°′が多く
、従って生体組繊細胞の侵入を容易とする繊維集合体層
と緻密な生体適合性プラスチック成形体層とで構成され
ているところにある。
The second characteristic is that the composite material at the skin penetration site has large pores (apparent specific surface area) or many open pores, and therefore has a fiber aggregate layer that facilitates the penetration of biological tissue cells. It is composed of a dense biocompatible plastic molded body layer.

従って、本発明の経皮留置カテーテルは生体皮膚組織と
強固な結合性を有するため、カテーテルと腹膜皮膚貫通
部からの感染症による腹膜炎の誘発が問題となっている
CARDカテーテルとして特に有用である。
Therefore, since the percutaneous indwelling catheter of the present invention has strong bonding properties with living body skin tissue, it is particularly useful as a CARD catheter, where induction of peritonitis due to infection from the catheter and the peritoneal skin penetration portion is a problem.

以下、本発明を詳述する。The present invention will be explained in detail below.

本発明に係る繊維集合体は繊維の一次加工品、例えば、
編組品、織物、不織布、フェルト或いは捲ぎ付は糸等を
例示し得る。それら繊維集合体の形態は複合材としての
使用目的、使用部位等に応゛じ適宜選択すれば良い。
The fiber aggregate according to the present invention is a primary processed product of fibers, for example,
Examples include braided products, woven fabrics, non-woven fabrics, felt, and threads. The form of these fiber aggregates may be appropriately selected depending on the purpose of use as a composite material, the site of use, etc.

!IIIIt集合体は組繊細胞の侵入を容易とするため
一般に20μ〜1000μの空隙又は開放気孔を有して
いることが好ましい。
! Generally, the IIIt aggregate preferably has voids or open pores of 20 μ to 1000 μ to facilitate the invasion of tissue cells.

繊維集合体を構成する繊維材料としては、生体適合性耐
熱繊維、例えば、炭素繊維、黒鉛繊維。
The fiber material constituting the fiber aggregate includes biocompatible heat-resistant fibers such as carbon fibers and graphite fibers.

シリカ、アルミナ、ジルコニア、アパタイト等よりなる
RmtaM或いはステンレス、チタン、ボロン等よりな
る金属繊維等を例示し得る。前記繊維は単独で又は複合
して用いる。
Examples include RmtaM made of silica, alumina, zirconia, apatite, etc., and metal fibers made of stainless steel, titanium, boron, etc. The above fibers may be used alone or in combination.

また、il雑の形態及び太さ等は特に限定されるもので
はなく、形態としては単糸、双糸、撚糸。
In addition, the form and thickness of the il miscellaneous yarn are not particularly limited, and the forms include single yarn, double yarn, and twisted yarn.

紡績糸、短繊維或いはウィスカー等を例示し得る。Examples include spun yarn, staple fibers, and whiskers.

繊維材料はそのまま或いはCV D (Chcmica
lV apor  D eposition)法等によ
り炭素被覆して用いる。特に、前記無機繊維或いは金属
繊維はさらに生体適合性を向上せしめるという観点から
炭素被覆したものが好ましい。
The fiber material can be used as it is or CVD (Chcmica
It is used after being coated with carbon by a method such as lV apor deposition. In particular, the inorganic fibers or metal fibers are preferably coated with carbon from the viewpoint of further improving biocompatibility.

CVDは、炭化水素例えばメタン、エチレン。CVD uses hydrocarbons such as methane, ethylene.

プロパン、ブタン、ベンゼン、トルエン等のガスをその
ガスの分解温度以上で分解し、繊維上に炭素被覆をする
ものである。その温度は600℃乃至3000℃で好ま
しくは700℃乃至2500℃である。
Gas such as propane, butane, benzene, toluene, etc. is decomposed at a temperature higher than the decomposition temperature of the gas, and the fibers are coated with carbon. The temperature is 600°C to 3000°C, preferably 700°C to 2500°C.

第1図はCVD法によって繊維集合体上へ炭素被覆する
際の留置の1例である。図中、14はCvD処理すべき
繊維集合体である。CVD被覆はアルゴン、水素、窒素
等の不活性ガス3をキャリアとして、メタン、ベンゼン
等4を600〜3000℃好ましくは100〜2500
℃の温度に保持した電気炉8の石英製、アルミナ製等の
管9に導入することで行なわれ、通常5〜180分で終
了させる。図中、1はガストラップ、1Gは石英又はア
ルミナ等よりなるボード、11は予熱部を示す。
FIG. 1 is an example of placement when carbon is coated onto a fiber aggregate by the CVD method. In the figure, 14 is a fiber aggregate to be subjected to CvD treatment. CVD coating is carried out using an inert gas such as argon, hydrogen, or nitrogen as a carrier and methane, benzene, etc. at 600 to 3000°C, preferably 100 to 2500°C.
It is carried out by introducing it into a tube 9 made of quartz, alumina, etc., of an electric furnace 8 maintained at a temperature of .degree. C., and is usually completed in 5 to 180 minutes. In the figure, 1 is a gas trap, 1G is a board made of quartz or alumina, etc., and 11 is a preheating section.

なお、得られたCVD被111m!合体を、必要に応じ
、更に不活性ガス雰囲気下、前記CvD被覆温度より高
い温度で熱処理しても良い。
In addition, the obtained CVD cover was 111m! If necessary, the coalescence may be further heat treated under an inert gas atmosphere at a temperature higher than the CvD coating temperature.

CvD処理はIIHの状態で行なってもよいが、編組、
1物、不織布、フェルト等に加工してから行うことが好
ましい。
CvD treatment may be performed in the IIH state, but
It is preferable to carry out the process after processing into a single object, nonwoven fabric, felt, etc.

本発明でいう生体適合性プラスデックはエラストマーも
含むもので、一般の市販の生体適合性プラスチックであ
ればいずれのものであってもよい。
The biocompatible plastic deck referred to in the present invention includes elastomers, and may be any general commercially available biocompatible plastic.

例えばポリ四フッ化エチレン等のフッ素系5lll。For example, fluorine-based materials such as polytetrafluoroethylene.

シリコンゴム等のシリコン樹脂、塩化ビニール樹脂、塩
化ビニリデン樹脂、フッ素化シリコンゴム。
Silicone resin such as silicone rubber, vinyl chloride resin, vinylidene chloride resin, fluorinated silicone rubber.

ポリエチレン、ポリプロピレン、ポリエステル。polyethylene, polypropylene, polyester.

ポリヒドロキシエチルメタアクリレート、ポリアクリル
アミド、ポリサルフォン、ポリーN−ビニルビOリドン
、セグメント化ポリウレタン等のプラスチックを例示し
得る。なお、これらのプラスチックは後述の接着をよく
するためにエツチング。
Plastics such as polyhydroxyethyl methacrylate, polyacrylamide, polysulfone, poly N-vinyl bi-Olidone, segmented polyurethane may be exemplified. In addition, these plastics are etched to improve adhesion as described below.

グロー放電処理又は表面処理剤等の塗布等により表面処
理することも好ましい。
It is also preferable to perform surface treatment by glow discharge treatment or coating with a surface treatment agent.

前記プラスチック材料からなる本発明のカテーテルはテ
ンコツ型、ライフカス型、TWH1’!或いはそれらの
改良品等であり、CAPDに用いられるカテーテルであ
ればその型式形状は特に限定されない。
The catheter of the present invention made of the above-mentioned plastic material is of the tenkotsu type, the life scrap type, and the TWH1'! Alternatively, the catheter may be an improved product thereof, and the type and shape thereof is not particularly limited as long as it is a catheter used for CAPD.

繊N集合体層とカテーテルとの接合は、IIM!1合体
層の多孔性と可撓性が損われない限り、任意の方法を用
いることができる。
The connection between the fiber-N aggregate layer and the catheter is performed using IIM! Any method can be used as long as the porosity and flexibility of the single combined layer are not compromised.

最も一般的には、カテーテル表面に接着剤を薄く塗布し
て、511℃集合体層をこれに圧着する。接着剤を用い
る代りに、カテーテル表面を熔融させ、これに繊維集合
体を融着させても良い。又、接着剤を塗布したり、部分
熔融させたカテーテル表面に直接is、*を編付けたり
捲き付けたり、或いは植毛する方法によっても良い。
Most commonly, a thin layer of adhesive is applied to the catheter surface and the 511°C aggregate layer is crimped thereto. Instead of using an adhesive, the surface of the catheter may be melted and the fiber aggregate may be fused thereto. Alternatively, it is also possible to apply an adhesive, knit or wrap IS, * directly on the surface of a partially melted catheter, or to implant hair.

前記接合に使用し得る接着剤としては、シリコン系接着
剤、ポリエチンー酢酸ビニル共重合体。
Adhesives that can be used for the bonding include silicone adhesives and polyethine-vinyl acetate copolymers.

ポリエステル、ナイロン、ウレタンエラストマー又は、
酢酸ビニル、アクリル樹脂等が挙げられる。
Polyester, nylon, urethane elastomer or
Examples include vinyl acetate and acrylic resin.

繊m間の接着されない部分は層全体の可撓性を示す為に
も、又生体mnaが侵入して固定化する上にも必要であ
る。
The non-adhered portions between the fibers m are necessary to show the flexibility of the entire layer and also to allow the living body mna to penetrate and be immobilized.

又、十分な強度が得られる場合には、カテーテルにam
を巻付けたり、sNを袋編状にして、プラスチック材料
にかぶせて固定する等の機械的な力を利用してもよい。
In addition, if sufficient strength can be obtained, am
Mechanical force may be used, such as by winding the sN or forming the sN into a bag-knitted shape and fixing it by covering the plastic material.

以下、本発明の経皮留置カテーテルの1実施態様を示す
One embodiment of the percutaneous indwelling catheter of the present invention will be shown below.

第2図は本発明の複合材を利用した持続的可動性腹膜透
析(CARD)のカテーテルを図示する。
FIG. 2 illustrates a continuous agility peritoneal dialysis (CARD) catheter utilizing the composite material of the present invention.

図中、15はシリコン製カテーテル、16は透析液容器
、11はトランスファチューブ、18はセラミックス又
はチタン等よりなるジヨイントで透析容凶16とトラン
スファチューブ及びトランスファチューブ17とカテー
テル15を接合する。
In the figure, 15 is a silicone catheter, 16 is a dialysate container, 11 is a transfer tube, and 18 is a joint made of ceramics, titanium, etc., which connects the dialysis chamber 16 and the transfer tube, and the transfer tube 17 and the catheter 15.

19は本発明の複合材であって、前記シリコンチューブ
カテーテル15の表面にCvD被覆シリカ繊維を袋編し
たものをシリコン接着剤で接合したもので、皮膚貫通部
位に位置する。
Reference numeral 19 is a composite material of the present invention, which is made by bonding bag-knitted CvD-coated silica fibers to the surface of the silicone tube catheter 15 with a silicone adhesive, and is located at the skin penetration site.

20はダクロン(ポリエステル)フェルト等よりなるカ
フで、通常カテーテル15を生体内部に固定する目的に
用いられるものである。21は透析液の流通弁である。
Reference numeral 20 denotes a cuff made of Dacron (polyester) felt or the like, which is normally used for the purpose of fixing the catheter 15 inside a living body. 21 is a dialysate flow valve.

本発明の複合材を適用した場合、前記カフ20は残して
も良いが、本発明の複合材19と皮膚組織との接合が強
固であるので必ずしもカフ20は必要としない。この場
合、カテーテルの橋造は単純となり、手術手段も著しく
簡略化できる。
When the composite material of the present invention is applied, the cuff 20 may be left in place, but since the bond between the composite material 19 of the present invention and the skin tissue is strong, the cuff 20 is not necessarily required. In this case, the construction of the catheter becomes simple and the surgical procedure can be significantly simplified.

前記第2図のカテー゛チルを臨床に適用したが、生体組
織との接合性に優れ、十分実用に供することが判明した
The catheter shown in FIG. 2 was applied clinically and was found to have excellent bonding properties with living tissue and to be fully usable for practical use.

なお、第2図は、テンコツ(T enckhoff)型
のカテーテルに本発明の複合材を装着した例を示すが、
ライ7カス(Life Cath)、THW型カテーテ
ル等、持続的可動性腹膜透析に用いられるカテーテルで
あれば型1種類に関係なく本発明の複合材を皮膚貫通部
に適用しても良い。
Note that FIG. 2 shows an example in which the composite material of the present invention is attached to a Tenckhoff-type catheter.
The composite material of the present invention may be applied to the skin-penetrating part of any catheter used for continuous mobile peritoneal dialysis, such as Life Cath or THW type catheter, regardless of the type.

又、繊維集合体として前記するCvD被覆シリカ繊維の
代りに炭素繊維、或いはCVD処理した炭素繊維もしく
は金属繊維もしくは無機繊維等を用いても生体皮膚組織
との結合性が良く実用に供することが確認された。
Furthermore, it has been confirmed that carbon fibers, CVD-treated carbon fibers, metal fibers, inorganic fibers, etc. can be used in place of the above-mentioned CvD-coated silica fibers as fiber aggregates, and have good bonding properties with living skin tissues and can be put to practical use. It was done.

参考例1本発明の耐熱性1111合体の製造例第1図の
ような留置を用いてシリカ繊維14よりなる厚さ0.5
8の平織布を石英ボード10に乗せた。
Reference Example 1 Example of manufacturing a heat-resistant 1111 combination of the present invention A silica fiber 14 with a thickness of 0.5
The plain woven fabric No. 8 was placed on a quartz board No. 10.

アルゴンガス3を1oo cc/stn及びメタンガス
4をI CCン1nを流し、混合ガスとして、1000
℃に保持した電気炉8内の石英管9に導入した。トラッ
プ1から電気炉のリボンヒーター11で予備加熱(50
0℃)した石英管9の内径は55閤φで均熱帯長は30
αである。最初アルゴンガス3のみ流し、電気炉を10
00℃まで界温し、その後、メタンガスをアルゴンガス
に加えて流した。約1時間流し、その後はアルゴン雰囲
気中で冷却した。この冷却されたCVD被覆シリカ繊維
布をとり出し、さらにアルゴン雰囲気中2000℃の温
度で30分熱処理を行なった。降温してCVD処理した
シリカ繊維布を得た。
100 cc/stn of argon gas 3 and 100 cc/stn of methane gas 4 were flowed as a mixed gas.
It was introduced into a quartz tube 9 in an electric furnace 8 maintained at .degree. Preheating from the trap 1 with the ribbon heater 11 of the electric furnace (50
The inner diameter of the quartz tube 9 heated to 0°C is 55 mm, and the soaking zone length is 30
It is α. At first, only argon gas was flowed and the electric furnace was turned on for 10 minutes.
The temperature was raised to 00° C., and then methane gas was added to the argon gas to flow. The mixture was allowed to flow for about 1 hour, and then cooled in an argon atmosphere. The cooled CVD-coated silica fiber cloth was taken out and further heat-treated at a temperature of 2000° C. for 30 minutes in an argon atmosphere. A silica fiber cloth subjected to CVD treatment was obtained by lowering the temperature.

【図面の簡単な説明】[Brief explanation of drawings]

第1図は、本発明で使用するC V D 511 I!
I!留置の説明図であり、第2図は本発明の経皮留置カ
テーテルの1つの実施例を示す図である。 1・・・・・・トラップ、2・・・・・・マントルヒー
ター、3・・・・・・不活性ガス、4・・・・・・CV
D用ガス、5.6.7・・・・・・流量計、8・・・・
・・電気炉、9・・・・・・石英管、10・・・・・・
石英ボード、11・・・・・・リボンヒーター、12・
・・・・・熱電対、13・・・・・・ビット、14・・
・・・・繊維集合体、15・・・・・・カテーテル、1
6・・・・・・透析液容器、17・・・・・・トランス
ファチューブ、18・・・・・・ジヨイント、19・・
・・・・本発明複合材、20・・・・・・カフ、旧・・
・・・・透析液流通弁。
FIG. 1 shows the C V D 511 I! used in the present invention.
I! FIG. 2 is an explanatory diagram of indwelling, and FIG. 2 is a diagram showing one embodiment of the percutaneous indwelling catheter of the present invention. 1...Trap, 2...Mantle heater, 3...Inert gas, 4...CV
D gas, 5.6.7...Flowmeter, 8...
...Electric furnace, 9...Quartz tube, 10...
Quartz board, 11... Ribbon heater, 12.
...Thermocouple, 13...Bit, 14...
... Fiber aggregate, 15 ... Catheter, 1
6... Dialysate container, 17... Transfer tube, 18... Joint, 19...
...Composite material of the present invention, 20...Cuff, old...
...Dialysate flow valve.

Claims (1)

【特許請求の範囲】[Claims] (1)生体適合性プラスチックよりなるカテーテルの皮
膚貫通部の表面に、耐熱性繊維集合体層を形成してなる
経皮留置カテーテル。
(1) A percutaneous indwelling catheter comprising a heat-resistant fiber aggregate layer formed on the surface of the skin-penetrating portion of a catheter made of biocompatible plastic.
JP60068669A 1985-04-01 1985-04-01 Subcataneous stay catheter Granted JPS61228876A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60068669A JPS61228876A (en) 1985-04-01 1985-04-01 Subcataneous stay catheter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60068669A JPS61228876A (en) 1985-04-01 1985-04-01 Subcataneous stay catheter

Publications (2)

Publication Number Publication Date
JPS61228876A true JPS61228876A (en) 1986-10-13
JPH0516872B2 JPH0516872B2 (en) 1993-03-05

Family

ID=13380348

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60068669A Granted JPS61228876A (en) 1985-04-01 1985-04-01 Subcataneous stay catheter

Country Status (1)

Country Link
JP (1) JPS61228876A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63278234A (en) * 1987-04-15 1988-11-15 Mitsubishi Electric Corp Silica glass solution feeder
JPH02501529A (en) * 1987-05-04 1990-05-31 ベインズ,アルバート ジェー. Biocompatible polyorganosiloxane composition for cell culture equipment

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5149157A (en) * 1974-10-28 1976-04-28 Toyota Motor Co Ltd Nijukanno mage kakoo okonauhoho oyobi sochi
JPS5626738U (en) * 1979-08-07 1981-03-12
JPS59174161A (en) * 1983-03-23 1984-10-02 呉羽化学工業株式会社 Body compatible plastic composite material

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5149157A (en) * 1974-10-28 1976-04-28 Toyota Motor Co Ltd Nijukanno mage kakoo okonauhoho oyobi sochi
JPS5626738U (en) * 1979-08-07 1981-03-12
JPS59174161A (en) * 1983-03-23 1984-10-02 呉羽化学工業株式会社 Body compatible plastic composite material

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63278234A (en) * 1987-04-15 1988-11-15 Mitsubishi Electric Corp Silica glass solution feeder
JPH02501529A (en) * 1987-05-04 1990-05-31 ベインズ,アルバート ジェー. Biocompatible polyorganosiloxane composition for cell culture equipment

Also Published As

Publication number Publication date
JPH0516872B2 (en) 1993-03-05

Similar Documents

Publication Publication Date Title
US5647858A (en) Zirconium oxide and zirconium nitride coated catheters
EP0358819B1 (en) Artificial skin
US4668222A (en) Percutaneous access device with removable tube
EP0996519B1 (en) Laminated metal structure
JP4401165B2 (en) Composite ePTFE / fiber prosthesis
US4897081A (en) Percutaneous access device
US4405319A (en) Porous titanium coating for blood access device
US3646616A (en) Prosthesis for implanting around a body duct such as the urethra and method of treating urinary incontinence
US5906596A (en) Percutaneous access device
US8252004B2 (en) Temporary retention device
EP1931280B1 (en) Patch for replacement of a portion of bladder wall following partial cystectomy
US8343567B2 (en) Method of treating the surface of a medical device with a biomolecule
EP0552474B1 (en) Artificial blood vessel
JPS61228876A (en) Subcataneous stay catheter
WO2009033528A1 (en) Patch for replacing a portion of bladder wall
CA1235856A (en) Biocompatible composite material
EP0164896B1 (en) Percutaneous access device
JPH06327757A (en) Bioimplant composite material and bioadaptable composite material
EP0093138B1 (en) Improved continuous ambulatory peritoneal dialysis system
EP0202917A2 (en) Implant device
JPS60163664A (en) Living body adaptable composite material
JPH02107268A (en) Internal stay tube and preparation thereof
JPH1015061A (en) Intraperitioneal indwelling catheter
JPH1199163A (en) Blood vessel prosthetic material
JP2005152181A (en) Embedding-type tubular treating tool